ANTI-EGFR OR ANTI-VEGF IN FIRST-LINE RAS WILD-TYPE METASTASTIC CRC PATIENTS: CAN WE DEFINE AN "OPTIM...

CALGB/SWOG 80405: Analysis of patients undergoing surgery as part of treatment strategy

A. Venook